If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

Share Price is delayed by 15 minutes
Get Live Data
1,032.50    7.00 (0.68%)
Bid:
1,032.00
Ask:
1,032.50
Spread: 0.50 (0.048%)
Market Cap: £25.75b
PRU Live PriceLast checked at - London Stock Exchange

Intraday Prudential Share Chart

Repurchase to neutralise share issuances

15 Dec 2025 07:00

RNS Number : 4676L
Prudential PLC
15 December 2025
 

Prudential plc

 

Repurchase Programme to neutralise 2025 share issuances for scrip dividend

 

Prudential plc (the "Company") announces that it will commence a share repurchase programme in respect of c. 2,200,000[1] ordinary shares of 5 pence each ("Ordinary Shares"), in the issued share capital of the Company (the "Programme").

 

The purpose of the Programme is to reduce the issued share capital of the Company to offset dilution from shares issued under the scrip dividend alternative in respect of the 2024 second interim dividend and the 2025 first interim dividend of 16.29 and 7.71 US cents per Ordinary Share, respectively. Based on the total number of Ordinary Shares in issue announced on 12 December 2025, the Programme approximates to 0.09% of the Company's issued share capital. The Directors consider the Programme to be in the best interests of the Company and of its shareholders generally. Given its small size, the implementation of the Programme is expected to marginally enhance earnings per share.

 

The Company intends to make further repurchases of its Ordinary Shares in future including in order to offset issuances under the scrip dividend scheme (if offered) and any expected dilution from the vesting of awards under employee and agent share schemes. The Company will make further announcements in respect of any such repurchases in due course.

 

Detailed terms of the Programme

 

The Company has entered into an arrangement with Merrill Lynch International ("MLI") (acting as riskless principal) to conduct the repurchases in respect of the Programme on its behalf.

 

The arrangement with MLI enables the purchase of Ordinary Shares for a period from 15 December 2025, and will complete no later than 19 December 2025. The aggregate maximum pecuniary amount allocated to the Programme is GBP 31 million (exclusive of associated fees, expenses and stamp duty) (equivalent to HKD 322.2 million and USD 41.4 million, based on the closing exchange rate between USD and GBP and USD and HKD as of 12 December 2025 HKT).

 

MLI may effect purchases of Ordinary Shares under the Programme on the London Stock Exchange and/or other trading venues[2] for subsequent purchase by the Company. Purchases by the Company will be treated as on-exchange transactions subject to the Listing Rules of the London Stock Exchange and as on-market purchases for the purpose of the Hong Kong Code on Share Buy-Backs. .The Company intends that any Ordinary Shares purchased will be cancelled.

 

The Programme will run concurrently with the US$500 million third and final tranche of the Company's US$2 billion share buyback programme, announced on 1 July 2025 and also being conducted by MLI (acting as riskless principal).

 

The Programme is in accordance with the Company's general authority to purchase a maximum of 262,668,701 Ordinary Shares granted by shareholders at the Company's 2025 Annual General Meeting. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 9 of the UK Listing Rules, the Hong Kong Listing Rules and the Hong Kong Code on Share Buy-backs. No purchase of Ordinary Shares will be conducted on the Hong Kong Stock Exchange. No repurchases will be made in respect of the Company's American Depositary Receipts.

 

The Company will make further announcements in due course following any repurchase of shares. There is no guarantee that the Programme will be implemented in full or that any shares will be repurchased by the Company.

Additional information

About Prudential plc

Prudential provides life and health insurance and asset management in Greater China, ASEAN, India and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (HKEX: 2378) and the London Stock Exchange (LSE: PRU). It also has a secondary listing on the Singapore Stock Exchange (SGX: K6S) and a listing on the New York Stock Exchange (NYSE: PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

 

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

https://www.prudentialplc.com/

 

 

Contact

 

Media

Investors/Analysts

Simon Kutner

+44 (0)7581 023260

Patrick Bowes

+852 9611 2981

Sonia Tsang

+852 5580 7525

William Elderkin

+44 (0)20 3977 9215

Ming Hau

+44 20 3977 9293

Bosco Cheung

+852 2918 5499

Tianjiao Yu

+852 2918 5487

 


[1] Two million, one-hundred and ninety-seven-thousand, and six-hundred sixty-nine (2,197,669) Ordinary Shares

[2] Being any multilateral trading facility operated by Turquoise Global Holdings Limited, CHI-X and BATS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIAFFLFLIE
Date   Source Headline
6th Jun 20239:33 amRNSPublication of a Prospectus
2nd Jun 202310:48 amRNSOverseas Regulatory Announcement - Grant of Awards
2nd Jun 202310:46 amRNSDirector/PDMR Shareholding
2nd Jun 202310:40 amRNSOverseas Regulatory Announcement - Grant of Awards
31st May 20232:58 pmRNSBlock listing six monthly return
31st May 20239:39 amRNSTotal Voting Rights
31st May 20237:00 amRNSPrudential appoints Ben Bulmer as CFO
26th May 20232:59 pmRNSDirector/PDMR Shareholding
25th May 20232:04 pmRNSDirectorate Change
25th May 20232:00 pmRNSResult of AGM
23rd May 202312:23 pmRNSDirector/PDMR Shareholding
22nd May 20233:06 pmRNSOverseas Regulatory Announcement - Grant of Awards
16th May 202310:44 amRNSDirector/PDMR Shareholding
16th May 202310:38 amRNSDirector/PDMR Shareholding
12th May 202312:33 pmRNSDirector/PDMR Shareholding
12th May 202312:26 pmRNSDirector/PDMR Shareholding
28th Apr 20239:47 amRNSTotal Voting Rights
28th Apr 20237:00 amRNSPrudential Plc - Business Performance Update
27th Apr 20239:53 amRNSDividend Rate Achieved
21st Apr 20239:44 amRNSNotice of AGM
13th Apr 202312:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20239:30 amRNSDirector/PDMR Shareholding
31st Mar 20232:04 pmRNSTotal Voting Rights
28th Mar 20239:50 amRNSDirector/PDMR Shareholding
23rd Mar 20232:26 pmRNSAnnual Report and Account 2022 and Form 20-F
23rd Mar 202311:00 amRNSBlock Listing Application
22nd Mar 202311:20 amRNSDirector/PDMR Shareholding
22nd Mar 202311:14 amRNSDirector/PDMR Shareholding
20th Mar 202310:28 amRNSDirector/PDMR Shareholding
15th Mar 20237:05 amRNSDividend Declaration
15th Mar 20237:01 amRNSPrudential plc – FY22 Results – Risk Factors
15th Mar 20237:01 amRNSPrudential plc – FY22 Results – Additional info
15th Mar 20237:00 amRNSPrudential plc – FY22 Results – EEV
15th Mar 20237:00 amRNSPrudential plc – FY22 Results – Business Review
15th Mar 20237:00 amRNSPrudential plc – FY22 Results – IFRS
14th Mar 20239:10 amRNSHolding(s) in Company
14th Mar 20239:05 amRNSDirector/PDMR Shareholding
28th Feb 20239:51 amRNSProposed issuer substitution of certain securities
28th Feb 20238:39 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSAppointment of Chief Executive
14th Feb 20238:32 amRNSDirector/PDMR Shareholding
9th Feb 202310:45 amRNSDirector/PDMR Shareholding
31st Jan 20239:50 amRNSTotal Voting Rights
27th Jan 202311:28 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSPrudential plc to open branch in Macau
20th Jan 20239:08 amRNSRedemption of Senior Bonds due 2023
12th Jan 20239:36 amRNSDirector/PDMR Shareholding
11th Jan 20239:31 amRNSDirector/PDMR Shareholding
30th Dec 20229:44 amRNSTotal Voting Rights
23rd Dec 202210:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.